FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372513003: Epoprostenol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197806016 Epoprostenol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211048013 Epoprostenol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2647459019 Prostaglandin I2 en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2647460012 Prostacyclin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2647461011 Prostaglandin PGI>2< en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
50761000195110 epoprostenolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
809101000172119 époprosténol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
50017131000188115 prostaglandine I2 fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
64861000195117 Epoprostenol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
235941000195114 Prostacyclin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
235951000195112 Prostaglandin I>2< de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
235961000195110 PGI2 - Prostaglandin I2 de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Epoprostenol (substance) Is a Prostaglandin group I false Inferred relationship Some
Epoprostenol (substance) Is a Prostacyclin PGI2 (substance) true Inferred relationship Some
Epoprostenol (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Platelet aggregation inhibitor (disposition) true Inferred relationship Some
Epoprostenol (substance) Is a Platelet aggregation inhibitor true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Epoprostenol sodium Is a False Epoprostenol (substance) Inferred relationship Some
Product containing epoprostenol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Epoprostenol (substance) Inferred relationship Some 1
Epoprostenol 1.5mg powder and solvent for infusion vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Epoprostenol (substance) Inferred relationship Some
Epoprostenol adverse reaction Causative agent (attribute) True Epoprostenol (substance) Inferred relationship Some 1
Allergy to epoprostenol (finding) Causative agent (attribute) False Epoprostenol (substance) Inferred relationship Some
époprosténol 500 microgrammes, fiole de poudre et solvant pour perfusion The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Epoprostenol (substance) Inferred relationship Some
Prostacyclin measurement Component True Epoprostenol (substance) Inferred relationship Some 1
Allergy to epoprostenol (finding) Causative agent (attribute) True Epoprostenol (substance) Inferred relationship Some 1
Epoprostenol sodium This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Epoprostenol (substance) Inferred relationship Some
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Epoprostenol (substance) Inferred relationship Some 1
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Epoprostenol (substance) Inferred relationship Some 1
Epoprostenol-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Epoprostenol (substance) Inferred relationship Some 1
Product containing only epoprostenol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Epoprostenol (substance) Inferred relationship Some 1
Product containing only epoprostenol in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Epoprostenol (substance) Inferred relationship Some 1
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for infusion vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Epoprostenol (substance) Inferred relationship Some 1
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Epoprostenol (substance) Inferred relationship Some 1
Epoprostenol (as epoprostenol sodium) 1.5 mg powder for solution for infusion and/or injection vial This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Epoprostenol (substance) Inferred relationship Some 1
Product containing precisely epoprostenol (as epoprostenol sodium) 500 microgram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Epoprostenol (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start